Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Helen Rees, Frances Ayres et al.|PLOS Global Public Health|2024Cited by 12
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Helen Rees, Jinal N. Bhiman et al.|medRxiv|2023Cited by 5